Shams Noori Pharma Trading Company Pharmaceutical Import Profile — Afghanistan (DGFT 2022–2026)

Name: Shams Noori Pharma Trading Company Pharmaceutical Import Records from India — 9 Products, $9.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Shams Noori Pharma Trading Company — Pharmaceutical Importer Profile (2026) | 9 Products, $9.8M Trade | TransData Nexus

Shams Noori Pharma Trading Company

Pharmaceutical Importer · Afghanistan · Gastrointestinal Focus · $9.8M Total Trade · DGFT Verified

Shams Noori Pharma Trading Company is a pharmaceutical importer based in Afghanistan with a total trade value of $9.8M across 9 products in 7 therapeutic categories. Based on 328 verified import shipments from Indian Customs (DGFT) records, Shams Noori Pharma Trading Company is the #1 buyer in 1 product including Domperidone. Shams Noori Pharma Trading Company sources from 15 verified Indian suppliers, with Combitic Global Caplet Private Limited accounting for 68.2% of imports.

Shams Noori Pharma Trading Company — Import Portfolio & Supplier Network

Shams Noori Pharma Trading Company import network — 9 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Shams Noori Pharma Trading Company?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Combitic Global Caplet Private Limited	$10.8M	1,285	68.2%
Ancalima Lifesciences Limited	$1.3M	172	8.3%
Innova Captab Limited	$928.1K

What Formulations Does Shams Noori Pharma Trading Company Import?

Formulation	Value	Ships
Omeprazole capsule i.p. 20MG ( grucid	$444.3K	18
Diclofenac sodium, paracetamol	$431.3K	27
Paracetamol, phenylephrine	$399.1K	20
Paracetamol, diclofenac sodium and	$273.3K	8
Pharma. goods/harmless	$231.8K	9
Pantoprazole and domperidone tablets	$204.5K	16
Rifampicin capsules i.p. 300 MG batch	$184.6K	8
Domperidone 10 MG and lansoprazole 30 MG	$179.8K	16
Paracetamol and chlorpheniramine	$177.0K	12
Omeprazole capsule i.p. 20MG (grucid	$163.7K	9
Ibuprofen tablets IP 400MG batch	$150.9K	6
Levofloxacin tablet IP 500MG	$145.9K	7
Paracetamol phenylephrine	$118.3K	3
Paracetamol phenylephrine hydrochloride chlorpheniramine maleate and caffeinetablets cofcal +	$118.3K	3
Omeprazole capsule i.p. 20MG grucid	$115.2K	3

Shams Noori Pharma Trading Company imports 1,299 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 9 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Domperidone	Gastrointestinal	$2.7M	133	7.1%	1
2	Phenylephrine	Respiratory & OTC	$1.9M	39	2.3%	5
3	Omeprazole	Gastrointestinal	$1.6M	31	0.2%	18
4	Diclofenac	Analgesics & Antipyretics	$1.4M	29	0.4%	4
5	Cetirizine	Antihistamines & Allergy	$1.0M	20	0.6%	12
6	Chlorpheniramine	Antihistamines & Allergy	$615.3K	55	0.7%	12
7	Levofloxacin	Antibiotics	$500.0K	10	0.7%	9
8	Norfloxacin	Advanced Antibiotics	$77.7K	8	0.9%	16
9	Paracetamol Caffeine	Combination Drugs	$18.0K	3	1.3%	9

Shams Noori Pharma Trading Company imports 9 pharmaceutical products across 7 categories into Afghanistan totaling $9.8M. The company is the #1 buyer for 1 product: Domperidone.

Shams Noori Pharma Trading Company — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Shams Noori Pharma Trading Company is a prominent pharmaceutical importer based in Kabul, Afghanistan. Established to address the growing demand for quality medicines, the company plays a pivotal role in the Afghan pharmaceutical distribution network. Operating as a primary wholesaler, Shams Noori Pharma Trading Company sources a diverse range of pharmaceutical products from international suppliers, ensuring their availability across Afghanistan. The company's strategic location in Kabul facilitates efficient distribution throughout the country, catering to both urban and rural healthcare facilities.

The company's headquarters are situated at Office No. 2 3, Haqmal Plaza, Hotel 3rd Part of Khair Khana, District 11, Kabul, Afghanistan. This central location enables Shams Noori Pharma Trading Company to effectively manage its operations and maintain strong relationships with suppliers and customers alike.

2Distribution Network

Shams Noori Pharma Trading Company operates a centralized distribution model from its Kabul headquarters. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in Kabul suggests a well-organized distribution network capable of reaching various regions within Afghanistan. The company's extensive import activities, with a total of 328 shipments from India, indicate a robust logistics framework supporting its operations.

3Industry Role

As a primary wholesaler, Shams Noori Pharma Trading Company serves as a critical link in Afghanistan's pharmaceutical supply chain. By importing a wide array of pharmaceutical products, the company ensures that essential medicines are accessible to healthcare providers across the country. Its role is vital in maintaining the flow of medical supplies, thereby supporting the overall healthcare infrastructure in Afghanistan.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Shams Noori Pharma Trading Company

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Shams Noori Pharma Trading Company exhibits a high degree of sourcing concentration, with 68.2% of its total import value ($10.8 million) attributed to COMBITIC GLOBAL CAPLET PRIVATE LIMITED. This significant reliance on a single supplier suggests a strategic partnership aimed at ensuring consistent product quality and supply. However, such concentration also poses potential risks, including supply chain disruptions in the event of issues with the primary supplier. The company's diversified sourcing from 15 unique Indian suppliers indicates a proactive approach to mitigating these risks by not solely depending on one source.

2Supply Chain Resilience

The resilience of Shams Noori Pharma Trading Company's supply chain is bolstered by its relationships with multiple Indian suppliers, including COMBITIC GLOBAL CAPLET PRIVATE LIMITED, ANCALIMA LIFESCIENCES LIMITED, and INNOVA CAPTAB LIMITED. This diversification allows the company to adapt to potential disruptions from any single supplier. While specific details about backup suppliers and shipping routes are not publicly available, the company's extensive import activities and supplier network suggest a well-structured and resilient supply chain capable of maintaining steady product availability in Afghanistan.

Strategic Implications

Importing Pharmaceuticals into Afghanistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Afghanistan

1Regulatory Authority & Framework

The Afghanistan Food and Drug Authority (AFDA), operating under the Ministry of Public Health, is the primary regulatory body overseeing pharmaceutical imports into Afghanistan. The AFDA is responsible for issuing licenses to pharmaceutical importers, ensuring compliance with national standards, and maintaining the quality and safety of medicines available in the country. The regulatory framework governing pharmaceutical imports includes the National Licensed Medicines List, which specifies the medicines authorized for importation and distribution within Afghanistan. (afda.gov.af)

2Import Licensing & GMP

To import pharmaceutical products into Afghanistan, companies must obtain an activity license from the General Directorate of Pharmacy Affairs (GDPA) under the Ministry of Public Health. This license is contingent upon compliance with guidelines on good manufacturing practices (GMP), distribution, and storage. Additionally, importers are required to secure an import permit from the GDPA, ensuring that only medicines registered in the National Licensed Medicines List are imported and distributed within Afghanistan.

3Quality & Labeling

Shams Noori Pharma Trading Company — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Shams Noori Pharma Trading Company's focus on importing products in the gastrointestinal, respiratory & OTC, and antihistamines & allergy therapeutic categories aligns with the prevalent health concerns in Afghanistan. The significant import value of Domperidone, a medication used to treat nausea and vomiting, indicates a high demand for gastrointestinal treatments. Similarly, the inclusion of Phenylephrine, Omeprazole, Diclofenac, and Cetirizine reflects the company's strategy to address common respiratory issues, pain management, and allergic reactions prevalent among the Afghan population.

2Sourcing Profile

Shams Noori Pharma Trading Company primarily sources generic pharmaceutical formulations from India, focusing on finished dosage forms such as tablets, capsules, syrups, and injections. This strategy allows the company to offer cost-effective medications without compromising on quality. India's well-established pharmaceutical manufacturing sector, known for its adherence to international quality standards, makes it a reliable source for these products.

3Market Positioning

By importing a diverse range of pharmaceutical products, Shams Noori Pharma Trading Company serves multiple segments of the Afghan market, including retail pharmacies, hospitals, and government tenders. Its extensive distribution network ensures that essential medicines are accessible to various healthcare providers, thereby supporting the overall healthcare infrastructure in Afghanistan.

Seller's Guide — How to Become a Supplier to Shams Noori Pharma Trading Company

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Shams Noori Pharma Trading Company. The company's diversified sourcing strategy indicates openness to establishing relationships with additional suppliers who can meet quality standards and regulatory requirements. Potential gaps in the company's current sourcing include the need for specialized formulations or products not currently offered by existing suppliers. Indian exporters can explore these opportunities by aligning their product offerings with the therapeutic categories prioritized by Shams Noori Pharma Trading Company.

2Requirements & Qualifications

Indian exporters seeking to supply Shams Noori Pharma Trading Company must ensure that their products are registered in the National Licensed Medicines List of Afghanistan. Compliance with international quality standards, such as WHO GMP or EU GMP certifications, is essential. Additionally, adherence to labeling requirements, including the use of official Afghan languages and compliance with serialization mandates, is necessary to meet regulatory standards.

3How to Approach

Frequently Asked Questions — Shams Noori Pharma Trading Company

What products does Shams Noori Pharma Trading Company import from India?

Shams Noori Pharma Trading Company imports 9 pharmaceutical products across 7 categories. Top imports: Domperidone ($2.7M), Phenylephrine ($1.9M), Omeprazole ($1.6M), Diclofenac ($1.4M), Cetirizine ($1.0M).

Who supplies pharmaceuticals to Shams Noori Pharma Trading Company from India?

Shams Noori Pharma Trading Company sources from 15 verified Indian suppliers. The primary supplier is Combitic Global Caplet Private Limited (68.2% of imports, $10.8M).

What is Shams Noori Pharma Trading Company's total pharmaceutical import value?

Shams Noori Pharma Trading Company's total pharmaceutical import value from India is $9.8M, based on 328 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Shams Noori Pharma Trading Company focus on?

Shams Noori Pharma Trading Company imports across 7 categories. The largest: Gastrointestinal (42.9%), Respiratory & OTC (19.8%), Antihistamines & Allergy (16.4%).

Get Full Shams Noori Pharma Trading Company Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.